Advances in Preclinical Modeling of NAFLD and NASH

|
The FATZO Mouse Model of Type 2 Diabetes Develops Non-Alcoholic Fatty Liver Disease (NAFLD)
 |
Hepatic Lipidosis and Fibrosis in Obese, Dysmetabolic, and Diabetic Non-Human Primates Quantified by Noninvasive Sonography
 |